LYRA
Lyra Therapeutics Inc.
Company Overview
| Mkt Cap | $9.77M | Price | $5.76 |
| Volume | 13.66K | Change | +4.35% |
| P/E Ratio | -0.1 | Open | $5.53 |
| Revenue | $1.5M | Prev Close | $5.52 |
| Net Income | $-93.4M | 52W Range | $3.81 - $37.50 |
| Div Yield | N/A | Target | $11.50 |
| Overall | 28 | Value | 40 |
| Quality | -- | Technical | 16 |
No chart data available
Stock Overview
Updated DailyLyra Therapeutics Inc. (LYRA) is a leading Manufacturing company in the Surgical and Medical Instrument Manufacturing industry, currently trading at $5.76 with a market capitalization of $9.77 million. The stock is approaching its 52-week lows, suggesting potential value opportunity, demonstrating unrated quality characteristics with a MarketXLS quality score of N/A.
Today's trading session shows LYRA with a volume of 14K shares. The stock opened up 0.18% from yesterday's close of $5.52. Current analyst estimates project earnings of $-18.46 per share for this year, with next year targeting $-6.64.
LYRA demonstrates concerning technical signals based on technical analysis. The company trades on the NSC exchange and operates alongside industry peers including OTIC, OTLC, OVAT-CA, ORTH-CA.
Key investment considerations for LYRA include concerning overall investment profile. The company offers a dividend yield of NA% and analyst price targets suggest potential upside of 99.7%. The stock shows elevated valuation levels based on valuation analysis.
Analysis generated on November 3, 2025 at 12:20 AM
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | LYRA | $5.76 | +4.3% | 13.66K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |